A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870

Study Identifier:

325-201-00003

ClinicalTrials.gov Identifier:

NCT04241965

EudraCT Identifier:

N/A

Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Study Contact Information:

N/A

Study Complete

Subscribe to Updates

Study Details

Medical Condition

Epilepsy

Study Drug

Drug: OPC-214870

Date

Feb 2020 - Oct 2021

Phase 1

Phase 2

Phase 3

Phase 4

N/A

Patient Requirements

Sex: Female & Male

Age: 18 - 64 Years

Requirements Information

Protocol Summary

Despite availability of several antiepileptic drugs (AEDs), in one-third of patients, epilepsy remains uncontrolled with AEDs. There is a need to develop new approaches to improve the existing medications to relieve patients' epilepsy, and OPC-214870 is being studied for this purpose.

Study Locations

Location

Status

Location

For additional information regarding sites, contact 844-687-8522

Ormond Beach, Florida, United States, 34174

Status

N/A